{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": null,
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Leverage",
            "Compounding Effect",
            "3x Daily Performance"
        ],
        "classification": "complex",
        "supporting_data": "The ETP Securities aim to provide 3 times the daily performance of the iShares MSCI South Korea ETF. This inherent leverage, coupled with the mention of 'Compounding Effect' which is magnified by leverage and longer holding periods, strongly indicates complexity. Furthermore, the product's objective is to pursue a '3x Long South Korea Investment Strategy', which explicitly involves derivatives to achieve the leveraged exposure. The KIID also states 'You are about to purchase a product that is not simple and may be difficult to understand' and classifies the product as risk class 7 out of 7.  MiFID II guidance, specifically the CESR paper and ESMA briefing, consistently flags leveraged products and those whose value is derived from other financial instruments or assets as complex due to the difficulty for retail investors to understand the associated risks, such as counterparty risk (though not explicitly mentioned here, it's inherent in synthetic replication) and the impact of compounding. The explicit mention of '3x Long' and the associated risks directly points to complexity under MiFID II principles."
    }
}